These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 18840110)
1. Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Klarin B; Wullt M; Palmquist I; Molin G; Larsson A; Jeppsson B Acta Anaesthesiol Scand; 2008 Sep; 52(8):1096-102. PubMed ID: 18840110 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics. Kujawa-Szewieczek A; Adamczak M; Kwiecień K; Dudzicz S; Gazda M; Więcek A Nutrients; 2015 Dec; 7(12):10179-88. PubMed ID: 26690209 [TBL] [Abstract][Full Text] [Related]
3. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Klarin B; Johansson ML; Molin G; Larsson A; Jeppsson B Crit Care; 2005 Jun; 9(3):R285-93. PubMed ID: 15987403 [TBL] [Abstract][Full Text] [Related]
4. A prospective randomised trial of probiotics in critically ill patients. McNaught CE; Woodcock NP; Anderson AD; MacFie J Clin Nutr; 2005 Apr; 24(2):211-9. PubMed ID: 15784480 [TBL] [Abstract][Full Text] [Related]
5. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. Lönnermark E; Friman V; Lappas G; Sandberg T; Berggren A; Adlerberth I J Clin Gastroenterol; 2010 Feb; 44(2):106-12. PubMed ID: 19727002 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility to antibiotics in isolates of Lactobacillus plantarum RAPD-type Lp299v, harvested from antibiotic treated, critically ill patients after administration of probiotics. Klarin B; Larsson A; Molin G; Jeppsson B Microbiologyopen; 2019 Feb; 8(2):e00642. PubMed ID: 29797784 [TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile-associated disease and mortality among the elderly critically ill. Zilberberg MD; Shorr AF; Micek ST; Doherty JA; Kollef MH Crit Care Med; 2009 Sep; 37(9):2583-9. PubMed ID: 19623053 [TBL] [Abstract][Full Text] [Related]
9. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929 [TBL] [Abstract][Full Text] [Related]
11. The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon. Goossens DA; Jonkers DM; Russel MG; Stobberingh EE; Stockbrügger RW Aliment Pharmacol Ther; 2006 Jan; 23(2):255-63. PubMed ID: 16393305 [TBL] [Abstract][Full Text] [Related]
12. Colonisation with digoxin-reducing strains of Eubacterium lentum and Clostridium difficile infection in nursing home patients. Bennett RG; Beamer BA; Greenough WB; Lindenbaum J; Bartlett JG J Diarrhoeal Dis Res; 1992 Jun; 10(2):87-92. PubMed ID: 1500644 [TBL] [Abstract][Full Text] [Related]
13. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249 [TBL] [Abstract][Full Text] [Related]
14. Lactobacillus and bifidobacteria combinations: a strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortality. Graul T; Cain AM; Karpa KD Med Hypotheses; 2009 Aug; 73(2):194-8. PubMed ID: 19359104 [TBL] [Abstract][Full Text] [Related]
15. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG; Ulutan F; Karakuş R Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [TBL] [Abstract][Full Text] [Related]
16. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M; Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Nieuwdorp M; van Nood E; Speelman P; van Heukelem HA; Jansen JM; Visser CE; Kuijper EJ; Bartelsman JF; Keller JJ Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1927-32. PubMed ID: 18808083 [TBL] [Abstract][Full Text] [Related]
18. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792 [TBL] [Abstract][Full Text] [Related]
19. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. Choudhry MN; Soran H; Ziglam HM QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220 [TBL] [Abstract][Full Text] [Related]
20. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]